For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220428:nRSb6744Ja&default-theme=true
RNS Number : 6744J Greencare Capital PLC 28 April 2022
28 April 2022
Greencare Capital PLC
("Greencare" or the "Company")
Directorate Changes
Greencare (AQSE: GRE), the investment company focused on investing in
medicinal cannabis, CBD and related wellness areas, announces the following
Board changes with immediate effect.
Mr Dominic White joins the Board as Non-Executive Chairman and Mr Martin
Walton has been appointed an independent Non-executive Director. Richard
Tonthat is stepping down as Chief Executive Officer in order to pursue other
business interests. Mr Guy Winterflood, who has been a Non-executive Director
since the Company's flotation, is also stepping down from the Board in order
to devote more time to his Chairmanship of Hempflax BV of The Netherlands, one
of Europe's largest growers of Hemp for industrial use.
Dominic White has over 25 years' experience in the investment sector and has
managed more than £3 billion of assets in the UK and Europe across multiple
sectors, in public companies, funds, joint-ventures and regulated activities.
He has held Board Level executive and non-executive positions in numerous
public companies and international investment institutions such as Henderson
Global Investors. Mr White is a member of the Institute of Chartered Financial
Analysts.
Mr White is Executive Chairman of AQSE quoted Eight Capital Partners plc and
is on the Board of a number of other private companies.
Martin Walton has many years' experience at Board level of companies within
the life sciences, biotech and medtech sectors/industries and within
investment and commercial banking. He is currently a Non-executive Director of
AIM listed Reneuron Group plc, a UK-based leader in Stem Cell and Exosomes
Technologies and is Chairman and CEO of Bradshaw Consulting Limited, a
strategic advisory group assisting companies and shareholders in creating,
generating and realising value from investments in life sciences and tech
sectors. He was previously at Excalibur Group Fund Management, was a
co-founder of Arix Bioscience plc and Arthurian Life Sciences Limited and has
held senior positions at Standard Bank and Toronto-Dominion Bank.
On joining the Board as Non-Executive Chairman, Mr White commented:
"On behalf of the Board, I would like to thank both Richard and Guy for their
commitment and service to the Company over the past two years, and wish them
well in their future endeavours. I also welcome Martin to the Board where his
combined life sciences and corporate finance and investment banking experience
will be of great value as the Company moves forward.
"I am pleased to have the opportunity to join Greencare at this time. The
CBD and cannabis sector continues to develop, and, as it matures, we expect
there to be opportunities, consolidation and rationalisation. Greencare will
continue to actively pursue acquisition and investment opportunities of
varying size in the cannabis and wellbeing space as well as taking a broader
view of opportunities within our stated investing strategy
Enquiries:
Greencare Capital plc C/O Wakbrook PR Limited
Dominic White +44 (0)20 7933 8780
Cairn Financial Advisers LLP +44 (0)20 7213 0880
AQSE Corporate Adviser
Jo Turner / James Lewis
Walbrook PR Limited +44 (0)20 7933 8780
Paul Vann/Nick Rome +44 (0)7768 807631
greencarecapital@walbrookpr.com
The following information is disclosed pursuant to Rule 4.9 of the AQSE Growth
Market Access Rulebook.
Dominic Andrew White (aged 50) holds or has held the following directorships
or partnerships in the past five years:
Current Directorships or Partnerships Previous Directorships or Partnerships
Dharma Dragon Ltd 12250088 Limited (previously Supply@Me Capital Limited)
Eight Capital Partners PLC Drumz PLC
E-Ledger Capital Solutions Ltd eMed Pharma Group Limited
IWEP Ltd Maximum Return System Ltd
K&C (Coleherne) Limited Ovio Wellness Limited
K&C (Newbury) Limited Supply@Me Capital PLC
K&C (Osprey) Limited Windustries Ltd
KCR (Kite) Limited Zamaz PLC
KCR (Southampton) Limited
KCR Residential Reit PLC
Maximum Return System Ltd
Maximum Return Systems Group LLP
White Amba Ltd
Mr White holds 8,000,000 Ordinary shares in the Company through a holding
entity, representing 54.1% of its issued share capital. Eight Capital Partners
plc, a company of which Mr White is a director and significant shareholder,
holds 2,560,000 ordinary shares in the Company representing 17.3% of its
issued share capital.
Mr White was a director of Ovio Wellness Limited, a health drinks company,
which was dissolved in February 2019 following the company being placed into
creditors voluntary liquidation in August 2017.
Mr Martin Charles Walton (aged 58 ) holds or has held the following
directorships or partnerships in the past five years:
Current Directorships or Partnerships Previous Directorships or Partnerships
ReNeuron Group plc Anontec Limited
Bradshaw Consulting Ltd Arix Capital Management Limited
Excalibur Medicines Ltd Arthurian Life Sciences Gp Limited
Igraine plc Arthurian Life Sciences Spv Gp Limited
Interrad Medical Inc Excalibur Fund Managers Limited
Iatros Capital Limited
Iota Sciences Limited
PZT Limited
Simbec-Orion Group Limited
Mr Walton does not hold any shares in the Company.
There is no further information to be disclosed pursuant to Rule 4.9 of the
AQSE Growth Market Rulebook.
Notes:
Greencare Capital plc is an investment company quoted on the Aquis Stock
Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October
2019 and its shares were admitted to trading on 30 December 2019.
The Company's investment strategy is to focus on investments in cannabis
sectors within countries predominantly in Europe whose jurisdictions have
well-developed and reputable laws and regulations for its production, research
and distribution; together with the CBD and hemp sectors.
The Company will invest directly or indirectly in public or private companies,
in supply and distribution chains, or other business associated with the
cannabis sector. Investments may take the form of debt or equity and it is
expected that such investments will ordinarily seek capital growth in the
medium term in preference to income.
The Company will not invest in the recreational cannabis sector, or in
entities or activities supported by it, nor any other related activities which
would be deemed illegal under UK legislation.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXKZGZDKRFGZZG